Fonar posts larger loss in fiscal 1999

Article

Increased revenue from its healthcare services business wasn’t enough to bring profitability to MRI developer Fonar. During its 1999 fiscal year (end-June), the Melville, NY-based open MRI developer posted revenues of $36.9 million, a 34% increase

Increased revenue from its healthcare services business wasn’t enough to bring profitability to MRI developer Fonar. During its 1999 fiscal year (end-June), the Melville, NY-based open MRI developer posted revenues of $36.9 million, a 34% increase over last year’s $27.6 million, but also sustained a net loss of $14.2 million, more than double 1998’s $5.7 million.

Fonar attributed its loss to low scanner sales and expenses related to the R&D of four new MRI products, but emphasized the growth of its physician practice management subsidiary, Health Management Corp. of America (HMCA). Its revenues climbed from $21.1 million in 1998 to $31.3 million in 1999, a 48% increase. In September, Fonar announced it will sell its MRI scanners to HMCA in an effort to upgrade select facilities and improve the subsidiary’s operating profits and productivity (SCAN 9/29/99).

In other Fonar news, the company moved to strengthen its stock repurchase program, announcing that it will purchase its shares on an ongoing basis and will consider a stock purchase plan for its employees. The company believes that it is on the cusp of dynamic growth as it continues R&D on works-in-progress scanners such as Open Sky MRI, Fonar OR-360, and Stand-Up MRI, for which it hopes to obtain clearance from the FDA next year. In an effort to facilitate this growth, Fonar also announced Oct. 27 that it has sold the stock of its subsidiary, Medical SNI of Haifa, Israel, which designs and develops medical imaging and archiving products. The sale will free Fonar from liabilities of roughly $1.2 million, and will give Fonar a pre-tax gain of $1 million.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.